Effect of Low-Dose, Long-Term Roxithromycin on Airway Inflammation and Remodeling of Stable Noncystic Fibrosis Bronchiectasis

Table 2

Effect of roxithromycin on the inflammatory cell (10⁶/mL) in induced sputum inflammatory markers in sputum.

Parameters	Group	Baseline	6 months	value; 6 months versus baseline	value; versus control at baseline	value; versus control at 6 months
Total cells	Control			0.069
	Roxithromycin			0.001	0.211	<0.001
Neutrophils	Control			0.055
	Roxithromycin			<0.001	0.129	<0.001
Macrophages	Control			0.079
	Roxithromycin			0.878	0.762	0.170
Lymphocytes	Control			0.915
	Roxithromycin			0.297	0.606	0.142

( = 0.001 and ) compared with 6 months of controls.